Gapping up
In reaction to strong earnings/guidance: TOPS +55%, WG +22%, CACC +2.7%, DO +1.7%.
M&A news: FLTX +39.7% (to be acquired by Verizon (VZ) for $60/share in cash, or ~$2.4 bln), PN +33.1% (Patriot National Board to consider an offer for a potential transaction with Ebix (EBIX), CZR +14.5% (Chinese consortium to buy Caesars Interactive Entertainment's social and mobile games business Playtika for $4.4 bln in cash).
Other news: IONS +23.3% (Phase 3 trial evaluating nusinersen in infantile-onset SMA met the primary endpoint; as a result, Biogen paid Ionis a $75 million license fee ), HRTX +20.3% (announces preliminary, 'positive', top-line efficacy results from two Phase 2 clinical studies of HTX-011 for the management of post-operative pain in patients undergoing bunionectomy and inguinal hernia repair), KGJI +17.3% (sells all of its interest in the Shanghai Creative Industry Park to Wuhan Lianfuda Investment Management for ~$ 171 mln), DRYS +17.1% (following TOPS earnings/move), SCYX +16.3% (announces its Phase 2 study evaluating SCY-078 as a treatment in patients initially treated with IV echinocandin therapy for invasive Candida infections met all primary objectives), ESEA +14.9% (following TOPS earnings/move), SPHS +5.1% (recent momentum name, not seeing anything new today), SPU +5.2% (recent momentum name, not seeing anything new today), MGT +5% (recent momentum name, not seeing anything new today), IPI +4.7% (light volume; obtains further waivers of certain covenants under its senior notes and its credit facility until September 30, 2016; also reaches agreement in principle with holders of its senior notes regarding revised terms), ESI +3.5% (light volume; Yude Zhang increases active stake ), SVU +0.2% (Several PE firms are preparing offers for Suvervalu's Save-A-Lot unit, according to Reuters).
Analyst comments: ETSY +3% (initiated with a Buy at Citigroup; tgt $14).
In reaction to strong earnings/guidance: TOPS +55%, WG +22%, CACC +2.7%, DO +1.7%.
M&A news: FLTX +39.7% (to be acquired by Verizon (VZ) for $60/share in cash, or ~$2.4 bln), PN +33.1% (Patriot National Board to consider an offer for a potential transaction with Ebix (EBIX), CZR +14.5% (Chinese consortium to buy Caesars Interactive Entertainment's social and mobile games business Playtika for $4.4 bln in cash).
Other news: IONS +23.3% (Phase 3 trial evaluating nusinersen in infantile-onset SMA met the primary endpoint; as a result, Biogen paid Ionis a $75 million license fee ), HRTX +20.3% (announces preliminary, 'positive', top-line efficacy results from two Phase 2 clinical studies of HTX-011 for the management of post-operative pain in patients undergoing bunionectomy and inguinal hernia repair), KGJI +17.3% (sells all of its interest in the Shanghai Creative Industry Park to Wuhan Lianfuda Investment Management for ~$ 171 mln), DRYS +17.1% (following TOPS earnings/move), SCYX +16.3% (announces its Phase 2 study evaluating SCY-078 as a treatment in patients initially treated with IV echinocandin therapy for invasive Candida infections met all primary objectives), ESEA +14.9% (following TOPS earnings/move), SPHS +5.1% (recent momentum name, not seeing anything new today), SPU +5.2% (recent momentum name, not seeing anything new today), MGT +5% (recent momentum name, not seeing anything new today), IPI +4.7% (light volume; obtains further waivers of certain covenants under its senior notes and its credit facility until September 30, 2016; also reaches agreement in principle with holders of its senior notes regarding revised terms), ESI +3.5% (light volume; Yude Zhang increases active stake ), SVU +0.2% (Several PE firms are preparing offers for Suvervalu's Save-A-Lot unit, according to Reuters).
Analyst comments: ETSY +3% (initiated with a Buy at Citigroup; tgt $14).